Does the HOMER trial signal the end for pharmacist medication reviews?

Pharmaceutical Journal

Volumn 274, Issue 7350, 2005, Pages 620-

  Bowyer, Caroline ^a   Barnett, Nina ^b  

^a Southampton City Primary Care Trust   (United Kingdom)

^b London SE and Eastern Specialist Pharmacy ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCESS TO INFORMATION; CLINICAL STUDY; COMPETENCE; DRUG USE; GENERAL PRACTITIONER; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; INCIDENCE; MEDICAL RECORD; MORTALITY; PHARMACY; PROFESSIONAL PRACTICE; PROFESSIONAL STANDARD; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT;

EID: 20044380940     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (2)

1. Hay JW. Pharmacist medication review study design concerns. BMJ 2005;330:E347.
2. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001;323:1340.